跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
THERVAN 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
THERVAN 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
THERVAN 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Laboratorios Alter S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 18, 2021
Approval ID
0e5493515f90c079
Company
Laboratorios Alter S.A.
Type
Standard
Approval Details
Approval Id
0e5493515f90c079
Drug Cima Aemps Name
THERVAN 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
85928
Holder Company Name
Laboratorios Alter S.A.
Marketing Company Name
Laboratorios Alter S.A.
Authorization Date
2021-04-18
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
40 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Laboratorios Alter S.A.
Active Ingredients
ATORVASTATINA CALCICA TRIHIDRATO
41.440 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 18, 2021
Approval ID
0e5493515f90c079
Type
Standard
Back to CIMA-AEMPS Approvals